EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature

Elena Massimino, Anna Paola Amoroso, Roberta Lupoli, Alessandro Rossi, Brunella Capaldo

Frontiers in Nutrition · 11.05.2023 · 10

DOI: 10.3389/fnut.2023.1178348 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Nutrition, online erschienen am 11.05.2023. Verfasst von Elena Massimino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycogen storage disease Type III (GSD III) is an autosomal recessive disease due to the deficiency of the debranching enzyme, which has two main consequences: a reduced availability of glucose due to the incomplete degradation of glycogen, and the accumulation of abnormal glycogen in liver and cardiac/skeletal muscle. The role of dietary lipid manipulations in the nutritional management of GSD III is still debated. A literature overview shows that low-carbohydrate (CHO) / high-fat diets may be beneficial in reducing muscle damage. We present a 24-year GSD IIIa patient with severe myopathy and cardiomyopathy in whom a gradual shift from a high-CHO diet (61% total energy intake), low-fat (18%), high-protein (21%) to a low-CHO (32 %) high-fat (45%) / high-protein (23%) diet was performed. CHO was mainly represented by high-fiber, low glycemic index food, and fat consisted prevalently of mono and polyunsaturated fatty acids. After a 2-year follow-up, all biomarkers of muscle and heart damage markedly decreased (by 50–75%), glucose levels remained within the normal range and lipid profile was unchanged. At echocardiography, there was an improvement in geometry and left ventricular function. A low -CHO, high-fat, high-protein diet seems to be safe, sustainable and effective in reducing muscle damage without worsening cardiometabolic profile in GSDIIIa. This dietary approach could be started as early as possible in GSD III displaying skeletal/cardiac muscle disease in order to prevent/minimize organ damage.

Schlagwörter

Stichwörter der Autor:innen

cardiomyopathycontinuous glucose monitoring (CGM)dietary interventionglycogen storage diseasehigh-fat dietmyopathy

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Department of Molecular Medicine and Medical Biotechnology, University Federico II, Naples, Italy.
  • Department of Translational Medicine, Section of Pediatrics, University Federico II, Naples, Italy.

Zitieren

APA

Massimino, E., Amoroso, A. P., Lupoli, R., Rossi, A., & Capaldo, B. (2023). Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature. Frontiers in Nutrition, 10. https://doi.org/10.3389/fnut.2023.1178348

Vancouver

Massimino E, Amoroso AP, Lupoli R, Rossi A, Capaldo B. Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature. Frontiers in Nutrition. 2023;10. doi:10.3389/fnut.2023.1178348

BibTeX
@article{Massimino2023,
  author = {Massimino, Elena and Amoroso, Anna Paola and Lupoli, Roberta and Rossi, Alessandro and Capaldo, Brunella},
  title = {Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature},
  journal = {Frontiers in Nutrition},
  year = {2023},
  volume = {10},
  doi = {10.3389/fnut.2023.1178348}
}
Kostenlos starten →